CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Photostimulation of extravasation of beta-amyloid through the model of blood-brain barrier
Authors
Ilana Agranovich
Tatiana Antonova
+14 more
Inna Blokhina
Elizaveta Boytsova
Maria Klimova
Juergen Kurths
Aysel Mamedova
Andrey Morgun
Nikita Navolokin
Elena Osipova
Oxana Semyachkina-Glushkovskaya
Alexander Shirokov
Andrey Terskov
Tingting Yu
Dan Zhu
Ekaterina Zinchenko
Publication date
1 January 2020
Publisher
Basel : MDPI AG
Doi
Cite
Abstract
Alzheimer’s disease (AD) is an incurable pathology associated with progressive decline in memory and cognition. Phototherapy might be a new promising and alternative strategy for the effective treatment of AD, and has been actively discussed over two decades. However, the mechanisms of therapeutic photostimulation (PS) effects on subjects with AD remain poorly understood. The goal of this study was to determine the mechanisms of therapeutic PS effects in beta-amyloid (Aβ)-injected mice. The neurological severity score and the new object recognition tests demonstrate that PS 9 J/cm2 attenuates the memory and neurological deficit in mice with AD. The immunohistochemical assay revealed a decrease in the level of Aβ in the brain and an increase of Aβ in the deep cervical lymph nodes obtained from mice with AD after PS. Using the in vitro model of the blood-brain barrier (BBB), we show a PS-mediated decrease in transendothelial resistance and in the expression of tight junction proteins as well an increase in the BBB permeability to Aβ. These findings suggest that a PS-mediated BBB opening and the activation of the lymphatic clearance of Aβ from the brain might be a crucial mechanism underlying therapeutic effects of PS in mice with AD. These pioneering data open new strategies in the development of non-pharmacological methods for therapy of AD and contribute to a better understanding of the PS effects on the central nervous system. © 2020 by the authors. Licensee MDPI, Basel, Switzerland
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Sustaining member
Repositorium für Naturwissenschaften und Technik
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:oa.tib.eu:123456789/7081
Last time updated on 23/07/2022